01730oam 2200481 a 450 991069850890332120090619110149.0(CKB)3460000000108636(OCoLC)274128841(EXLCZ)99346000000010863620081119d2008 ua 0engurbn|||||||||txtrdacontentcrdamediacrrdacarrierExamining the implications of drug importation[electronic resource] hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, second session, July 14, 2004Washington :U.S. G.P.O.,2008.iv, 278 pages digital, PDF fileS. hrg. ;108-923Title from title screen (viewed on Nov. 19, 2008)."Serial no. J-108-89."Includes bibliographical references.Examining the implications of drug importation Drug reimportationUnited StatesProduct counterfeitingUnited StatesImportsLaw and legislationUnited StatesConsumer protectionUnited StatesForeign trade regulationUnited StatesPharmaceutical policyUnited StatesDrug reimportationProduct counterfeitingImportsLaw and legislationConsumer protectionForeign trade regulationPharmaceutical policyGPOGPOGPOBOOK9910698508903321Examining the implications of drug importation3466624UNINA